- Home
- MRVI vs TERN Comparison
MRVI vs TERN Comparison
Compare MRVI & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- TERN
- Stock Information
- Founded
- MRVI 2014
- TERN 2017
- Country
- MRVI United States
- TERN United States
- Employees
- MRVI N/A
- TERN N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- MRVI Health Care
- TERN Health Care
- Exchange
- MRVI Nasdaq
- TERN Nasdaq
- Market Cap
- MRVI 347.5M
- TERN 298.1M
- IPO Year
- MRVI 2020
- TERN 2021
- Fundamental
- Price
- MRVI $2.16
- TERN $2.56
- Analyst Decision
- MRVI Hold
- TERN Buy
- Analyst Count
- MRVI 10
- TERN 6
- Target Price
- MRVI $7.59
- TERN $18.30
- AVG Volume (30 Days)
- MRVI 3.8M
- TERN 983.7K
- Earning Date
- MRVI 05-07-2025
- TERN 03-20-2025
- Dividend Yield
- MRVI N/A
- TERN N/A
- EPS Growth
- MRVI N/A
- TERN N/A
- EPS
- MRVI N/A
- TERN N/A
- Revenue
- MRVI $259,185,000.00
- TERN N/A
- Revenue This Year
- MRVI N/A
- TERN N/A
- Revenue Next Year
- MRVI $14.59
- TERN N/A
- P/E Ratio
- MRVI N/A
- TERN N/A
- Revenue Growth
- MRVI N/A
- TERN N/A
- 52 Week Low
- MRVI $2.07
- TERN $2.56
- 52 Week High
- MRVI $11.56
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- MRVI 28.06
- TERN 26.95
- Support Level
- MRVI $2.07
- TERN $3.07
- Resistance Level
- MRVI $2.43
- TERN $3.72
- Average True Range (ATR)
- MRVI 0.20
- TERN 0.22
- MACD
- MRVI 0.05
- TERN -0.03
- Stochastic Oscillator
- MRVI 14.06
- TERN 0.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.